Delivery of therapeutics to posterior eye segment: cell-encapsulating systems.
作者信息
Wong Francisca S Y, Tsang Ken K, Lo Amy C Y
机构信息
Department of Ophthalmology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Research Center of Heart, Brain, Hormone and Healthy Aging, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
出版信息
Neural Regen Res. 2017 Apr;12(4):576-577. doi: 10.4103/1673-5374.205093.
Abstract
摘要
相似文献
1
Delivery of therapeutics to posterior eye segment: cell-encapsulating systems.向眼后节递送治疗药物：细胞封装系统。
Neural Regen Res. 2017 Apr;12(4):576-577. doi: 10.4103/1673-5374.205093.
2
Cubosomes and other potential ocular drug delivery vehicles for macromolecular therapeutics.用于大分子治疗药物的立方液晶纳米粒及其他潜在眼部给药载体。
Expert Opin Drug Deliv. 2015;12(9):1513-26. doi: 10.1517/17425247.2015.1021680. Epub 2015 Mar 9.
3
A review on recent drug delivery systems for posterior segment of eye.眼部后段的近期药物输送系统综述。
Biomed Pharmacother. 2018 Nov;107:1564-1582. doi: 10.1016/j.biopha.2018.08.138. Epub 2018 Sep 5.
4
Modern drug delivery systems for targeting the posterior segment of the eye.用于靶向眼后段的现代药物递送系统。
Curr Pharm Des. 2015;21(42):6055-69. doi: 10.2174/1381612821666151027151847.
5
A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.一种用于治疗后节眼病的可植入眼内药物输送技术的综述。
J Pharm Sci. 2010 May;99(5):2219-39. doi: 10.1002/jps.21987.
6
Drug delivery to the posterior segment of the eye.药物向眼后段的递送。
Eur J Ophthalmol. 2011;21 Suppl 6:S20-6. doi: 10.5301/EJO.2010.6051.
7
Drug Delivery to the Posterior Segment of the Eye.药物递送至眼后段
Dev Ophthalmol. 2017;58:87-101. doi: 10.1159/000455276. Epub 2017 Mar 28.
8
Drug delivery to the posterior segment of the eye.药物向眼后段的递送。
Dev Ophthalmol. 2010;47:59-72. doi: 10.1159/000320074. Epub 2010 Aug 10.
9
Current and future ophthalmic drug delivery systems. A shift to the posterior segment.当前及未来的眼科药物递送系统。向眼后段的转变。
Drug Discov Today. 2008 Feb;13(3-4):135-43. doi: 10.1016/j.drudis.2007.11.002. Epub 2008 Jan 8.
10
Hydrogel Ring for Topical Drug Delivery to the Ocular Posterior Segment.用于眼部后段局部给药的水凝胶环
Curr Eye Res. 2016 May;41(5):653-61. doi: 10.3109/02713683.2015.1050738. Epub 2015 Aug 3.
引用本文的文献
1
Roles of biomaterials in modulating the innate immune response in ocular therapy.生物材料在眼部治疗中调节先天性免疫反应的作用。
Front Drug Deliv. 2023 Feb 15;3:1077253. doi: 10.3389/fddev.2023.1077253. eCollection 2023.
2
Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization.靶向 FSCN1 的口服小分子抑制剂治疗眼部血管新生。
J Transl Med. 2023 Aug 18;21(1):555. doi: 10.1186/s12967-023-04225-0.
3
Innovative Strategies for Drug Delivery to the Ocular Posterior Segment.药物递送至眼后段的创新策略。
Pharmaceutics. 2023 Jul 1;15(7):1862. doi: 10.3390/pharmaceutics15071862.
4
Nanomedicine and drug delivery to the retina: current status and implications for gene therapy.纳米医学与视网膜递药：现状及对基因治疗的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2022 Dec;395(12):1477-1507. doi: 10.1007/s00210-022-02287-3. Epub 2022 Sep 15.
5
Hyaluronic Acid-PEG-Based Diels-Alder Forming Hydrogels for Sustained Intraocular Delivery of Bevacizumab.基于透明质酸-聚乙二醇的 Diels-Alder 形成水凝胶用于持续眼内递送贝伐单抗。
Biomacromolecules. 2022 Jul 11;23(7):2914-2929. doi: 10.1021/acs.biomac.2c00383. Epub 2022 Jun 23.
6
The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization.使用 Matrigel 联合细胞封装技术在脉络膜新生血管小鼠模型中递送补体抑制剂。
Mol Vis. 2020 May 15;26:370-377. eCollection 2020.
7
Insulin-Producing Cell Transplantation Platform for Veterinary Practice.用于兽医实践的胰岛素产生细胞移植平台。
Front Vet Sci. 2020 Feb 12;7:4. doi: 10.3389/fvets.2020.00004. eCollection 2020.
8
Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.基于封装细胞技术递送补体抑制剂可减少小鼠模型中的脉络膜新生血管形成。
Transl Vis Sci Technol. 2018 Mar 9;7(2):3. doi: 10.1167/tvst.7.2.3. eCollection 2018 Mar.
本文引用的文献
1
Long-term Follow-up of Patients With Retinitis Pigmentosa Receiving Intraocular Ciliary Neurotrophic Factor Implants.接受眼内睫状神经营养因子植入的色素性视网膜炎患者的长期随访
Am J Ophthalmol. 2016 Oct;170:10-14. doi: 10.1016/j.ajo.2016.07.013. Epub 2016 Jul 25.
2
Sustained Delivery of Bioactive GDNF from Collagen and Alginate-Based Cell-Encapsulating Gel Promoted Photoreceptor Survival in an Inherited Retinal Degeneration Model.基于胶原蛋白和藻酸盐的细胞封装凝胶对生物活性胶质细胞源性神经营养因子的持续递送促进了遗传性视网膜变性模型中光感受器的存活。
PLoS One. 2016 Jul 21;11(7):e0159342. doi: 10.1371/journal.pone.0159342. eCollection 2016.
3
Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.用于2型黄斑毛细血管扩张症的睫状神经营养因子：1期安全性试验结果
Am J Ophthalmol. 2015 Apr;159(4):659-666.e1. doi: 10.1016/j.ajo.2014.12.013. Epub 2014 Dec 19.
4
Drug delivery techniques for treating age-related macular degeneration.治疗年龄相关性黄斑变性的药物输送技术。
Expert Opin Drug Deliv. 2014 Jan;11(1):61-8. doi: 10.1517/17425247.2013.859135. Epub 2013 Nov 13.
5
Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa.包裹细胞眼内植入物递送睫状神经营养因子治疗色素性视网膜炎的随机试验。
Am J Ophthalmol. 2013 Aug;156(2):283-292.e1. doi: 10.1016/j.ajo.2013.03.021. Epub 2013 May 10.
6
Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases.采用细胞包封技术的植入物进行睫状神经营养因子的两年眼内递释，用于治疗慢性视网膜退行性疾病。
Invest Ophthalmol Vis Sci. 2012 Nov 1;53(12):7484-91. doi: 10.1167/iovs.12-9970.
7
Optimization of 100 μm alginate-poly-L-lysine-alginate capsules for intravitreous administration.优化 100μm 海藻酸钠-聚-L-赖氨酸-海藻酸钠微胶囊用于玻璃体内给药。
J Control Release. 2012 Mar 28;158(3):443-50. doi: 10.1016/j.jconrel.2011.09.079. Epub 2011 Sep 24.
8
Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration.包裹细胞眼内植入物递送睫状神经营养因子治疗年龄相关性黄斑变性的地图样萎缩。
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6241-5. doi: 10.1073/pnas.1018987108. Epub 2011 Mar 28.
9
Drug carrier systems based on collagen-alginate composite structures for improving the performance of GDNF-secreting HEK293 cells.基于胶原蛋白-海藻酸盐复合结构的药物载体系统，用于改善分泌胶质细胞源性神经营养因子的人胚肾293细胞的性能。
Biomaterials. 2009 Feb;30(6):1214-21. doi: 10.1016/j.biomaterials.2008.11.017. Epub 2008 Dec 6.
10
Alginate-based microencapsulation of retinal pigment epithelial cell line for cell therapy.用于细胞治疗的基于藻酸盐的视网膜色素上皮细胞系微囊化
Biomaterials. 2008 Mar;29(7):869-76. doi: 10.1016/j.biomaterials.2007.10.056. Epub 2007 Nov 28.
Zotero 插件